IL13RA2 and central nervous system cancer: Here, we integrated IL13RA2 into a construct encoding for PDGFB and used the RCAS/Tva system to develop a novel immunocompetent GEMM that both recapitulates diffuse midline gliomas and expresses the human glioma-associated antigen IL13RA2.